NCT06130735 · RECRUITING

Impact of Intensive Computerized Cognitive Training

This trial is testing whether intensive computerized brain training can improve attention and executive function in people with mild cognitive difficulties caused by acquired brain injury — things like stroke or traumatic brain injury. Researchers also want to know what factors predict who benefits most. This is a Phase NA behavioral study, meaning it is evaluating a non-drug training program, not a medication, and is not yet proven to work.

You may qualify if

  • Patient of the Mass General Brigham Health System with primary attention and executive functioning difficulties and/or a diagnosis of mild cognitive disorder or mild neurocognitive disorder (non-amnestic profile), due to an acquired brain injury (ABI) sustained at least 12 months prior to study contact.
  • Ages 25-65 years old
  • Proficiency in English
  • Willing and able to complete all study-related activities for 12 months, including travel to Brigham and Women's Hospital (Boston) for four in-person assessment visits and two serum and saliva sample collections.
  • Access to a computer with webcam and stable internet.
  • A reliable study informant who can complete one questionnaire about participant's cognition/daily functioning, at four time points.

You're excluded if

  • History of alcohol or substance abuse, or dependence, within the past 2 years, as per DSM-5 criteria.
  • High likelihood of an underlying progressive neurodegenerative disorder.
  • Evidence of moderate to severe cognitive disorder, based on a score of 21 or less on the Mini-Mental Status Examination (MMSE) (Tombaugh \& McIntyre, 1992).
  • Patient Health Questionnaire (PHQ)-9 (Kroenke et al., 2010) Score ≥ 19, unless deemed by treating provider not to have active depression (e.g., adjustment disorder, grief reaction).
  • Active psychotic symptoms.
  • Severe sensory losses such that participants would unlikely be able to participate in the study training, even with substantial accommodations (self-report of extreme difficulty reading ordinary newspaper print or a performance-tested corrected vision test score of worse than 20/30).
  • Communication difficulties that prevent the participant from effectively participating in this highly interactive study protocol (based on interviewer's rating of a person's ability to be understood and to understand others).
  • Current participation in a pharmacological, or other interventional research trial.
  • Life expectancy of \< 2 years.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-11-05

View full record on ClinicalTrials.gov

All APOE4 clinical trials